FDA Authorizes Booster for Children Aged 5-11
May 17, 2022 1:12PM EDT
Aiden Arthurs receives the Pfizer-BioNTech Covid-19 Vaccine from Pharmacist Andrew Mac (R) at the Jewish Federation/JARC’s offices in Bloomfield Hills, Michigan, on May 13, 2021. – The US Food and Drug Administration (FDA) on May 10, 2021 authorized the use of the Pfizer-BioNTech Covid-19 vaccine for children aged 12 to 15 years old. (Photo by JEFF KOWALSKY / AFP) (Photo by JEFF KOWALSKY/AFP via Getty Images)
On Tuesday, the Food and Drug Administration authorized Pfizer-BioNTech booster shots for children ages 5 to 11.
Over 8 million children in that age group in the U.S. have received two shots of a Covid-19 vaccine.
Those children are now qualified to receive boosters five months after their second vaccine shots.
Only six percent of U.S. children in that age range have received just one vaccine.
More about:
